Cargando…

Lessons from Cancer Immunoediting in Cutaneous Melanoma

We will revisit the dual role of the immune system in controlling and enabling tumor progression, known as cancer immunoediting. We will go through the different phases of this phenomenon, exposing the most relevant evidences obtained from experimental models and human clinical data, with special fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aris, Mariana, Barrio, María Marcela, Mordoh, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424677/ https://www.ncbi.nlm.nih.gov/pubmed/22924051 http://dx.doi.org/10.1155/2012/192719

Ejemplares similares

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2015)

Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
por: Mordoh, Ana, et al.
Publicado: (2023)

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases
por: Mordoh, Ana, et al.
Publicado: (2022)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
por: Bravo, Alicia Inés, et al.
Publicado: (2023)

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
por: Podaza, Enrique, et al.
Publicado: (2020)

Cancer Immunoediting and beyond in 2021
por: Borroni, Elena Monica, et al.
Publicado: (2021)

Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges
por: Kunimasa, Kei, et al.
Publicado: (2020)

Novel strategies for cancer immunotherapy: counter-immunoediting therapy
por: Liu, Shaochuan, et al.
Publicado: (2023)

The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
por: Nirmal, Ajit J., et al.
Publicado: (2022)

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
por: Aris, Mariana, et al.
Publicado: (2019)

A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment
por: Mordoh, Jose, et al.
Publicado: (2013)

Cancer immunoediting hypothesis: history, clinical implications and controversies
por: Lasek, Witold
Publicado: (2022)

Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics
por: Najaflou, Meysam, et al.
Publicado: (2022)

Cancer immunoediting: A game theoretical approach
por: Tavakoli, Fatemeh, et al.
Publicado: (2021)

Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
por: Aris, Mariana, et al.
Publicado: (2015)

Cancer stem cell immunoediting by IFNγ
por: Galassi, Claudia, et al.
Publicado: (2023)

Expression of tumour-specific antigens underlies cancer immunoediting
por: DuPage, Michel, et al.
Publicado: (2012)

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
por: Łuksza, Marta, et al.
Publicado: (2022)

A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting
por: Pagura, Lucas, et al.
Publicado: (2014)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Cancer immunoediting by the innate immune system in the absence of adaptive immunity
por: O’Sullivan, Timothy, et al.
Publicado: (2012)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

A proposed role for neutrophil extracellular traps in cancer immunoediting
por: Berger-Achituv, Sivan, et al.
Publicado: (2013)

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
por: Takeda, Kazuyoshi, et al.
Publicado: (2017)

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
por: Houlahan, Kathleen E., et al.
Publicado: (2023)

Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance
por: Katopodi, Theodora, et al.
Publicado: (2022)

Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition
por: Giúdice, Antonela Del, et al.
Publicado: (2020)

Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting
por: Matsushita, Hirokazu, et al.
Publicado: (2012)

Have Cells Harboring the HIV Reservoir Been Immunoedited?
por: Huang, Szu-Han, et al.
Publicado: (2019)

Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories
por: Mizuno, Shinichi, et al.
Publicado: (2021)

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
por: Pampena, María B., et al.
Publicado: (2018)

Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma
por: Mazzocco, Marta, et al.
Publicado: (2015)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

The Janus Face of Death Receptor Signaling during Tumor Immunoediting
por: O’ Reilly, Eimear, et al.
Publicado: (2016)

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting
por: Mota, Talia M., et al.
Publicado: (2019)

Gene essentiality for tumour growth influences neoantigen‐directed immunoediting
por: Bang, Hyoeun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bq9qpugucks33guhviunb0joim